Evaluation of the phototoxic properties of some hypolipidemics in vitro: Fenofibrate exhibits a prominent phototoxic potential in the UVA and UVB region

Journal of Dermatological Science

Volumn 13, Issue 2, 1996, Pages 172-177

  Diemer, Stefan ^a   Eberlein König, Bernadette ^a   Przybilla, Bernhard ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Benzophenone; Fibric acid derivatives; Hypolipidemics; Photohemolysis; Phototoxicity

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; CLOFIBRATE; FENOFIBRATE; GEMFIBROZIL;

ARTICLE; ERYTHROCYTE; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IRRADIATION; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANTILIPEMIC AGENTS; BEZAFIBRATE; CLOFIBRATE; DERMATITIS, PHOTOTOXIC; DRUG EVALUATION, PRECLINICAL; GEMFIBROZIL; HEMOLYSIS; HUMANS; PROCETOFEN; ULTRAVIOLET RAYS;

EID: 0030297571     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(96)00552-X     Document Type: Article

References (28)

1. [1] Illingworth DR: An overview of lipid-lowering drugs. Drugs 36 (Suppl 3): 63-71, 1988.
2. [2] Balfour JA, McTavish D, Heel RC: Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs 40: 260-290, 1990.
3. [3] Sgro C, Escousse A: Effet indesirables des fibrates (hors foie et muscle). Therapie 46: 351-354, 1991.
4. [4] Sirtori CR, Calabresi L, Werba JP, Franceschini G: Tolerability of fibric acids. Comparative data and biochemical bases. Pharmacol Res 26: 243-260, 1991.
5. [5] Arif MA, Vahrman J: Skin eruption due to clofibrate. Lancet 2: 1202, 1975.
6. [6] Murata Y, Tani M, Amano M: Erythema multiforme due to clofibrate. Am J Acad Dermatol 18: 381-382, 1988.
7. [7] Howard EJ, Brown SM: Clofibrate-induced antinuclear factor and lupus-like syndrome. J Am Med Assoc 226: 1358-1359, 1973.
8. [8] Blane GF: Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives. Am J Med 83: 26-36, 1987.
9. [9] Kloer HU: Structure and biochemical effects of fenofibrate. Am J Med 83: 3-8, 1987.
10. [10] Dujovne CA, Weiss P, Bianchine JR: Comparative clinical therapeutic trial with two hypolilpidemic drugs: clofibrate and nafenopin. Clin Pharmacol Ther 12: 117-125, 1971.
11. [11] Heid E, Samsoen M, Juillard J, Eberst E, Fossereau J: Eruptions papulovésiculeuse endogènes à méthyldopa et au clofibrate. Ann Derm Venereol 104: 494-496, 1977.
12. [12] Merino V, Menéndez F, Calco MJ, Iglesias L: Fotosensibilidad a fenofibratos. Actas Dermo-Sif 80: 703-704, 1989.
13. [13] Leroy D, Dompmartin A, Lorier E, Leport Y, Audebert C: Photosensitivity induced by fenofibrate. Photodermatol Photoimmunol Photomed 7: 136-137, 1990.
14. [14] Serrano G, Fortea JM, Latasa JM, Milian F, Janes C, Bosca F, Miranda MA: Photosensitivity induced by fibric acid derivatives and its relation to photocontact dermatitis to ketoprofen. J Am Acad Dermatol 27: 204-208, 1992.
15. [15] Gardeazabal J, Gonzalez M, Izu R, Gil N, Aguirre A, Diaz-Perez JL: Phenofibrate-induced lichenoid photodermatitis. Photodermatol Photoimmunol Photomed 9: 156-158, 1993.
16. [16] Jeanmougin M, Manciet JR, De Prost Y, Reyagagne P, Pinquier L, Dubertret L: Photo-allergie au fénofibrate. Ann Dermatol Venereol 120: 549-554, 1993.
17. [17] Mutzhas MF, Hölzle E, Hofmann C, Plewig G: A new apparatus with high irradiation energy between 320-460 nm: physical description and dermatological applications. J Invest Dermatol 76: 42-47, 1981.
18. [18] Przybilla B, Georgii A, Bergner T, Ring J: Demonstration of quinolone phototoxicity in vitro. Dermatologica 181: 98-103, 1990.
19. [19] Vargas F, Rivas C, Canudas N: Formation of a perbenzoic acid derivative in the photodegradation of fenofibrate: phototoxicity studies on erythrocytes. J Pharm Sci 82: 590-591, 1993.
20. [20] Vargas F, Canudas N, Miranda MA, Boscá F: In vitro phototoxicity of clofibrate. Photochemical and photohemolytic studies on its metabolite clofibiric acid. J Photochem Photobiol B: Biol 21: 61-67, 1993.
21. [21] Vargas F, Canudas N: Photolability and photohemolytic studies of fibrates. Pharmazie 48: 900-904, 1993.
22. [22] Vargas F, Canudas N, Miranda MA, Bosca F: Photodegradation and in vitro phototoxicity of fenofibrate, a photosensitizing anti-hyperlipoproteinemic drug. Photochem Photobiol 58: 471-476, 1993.
23. [23] Miranda MA, Bosca F, Vargas F, Canudas N: Photosensitization by fenofibrate. II. In vitro phototoxicity of the major metabolites. Photochem Photobiol 59: 171-174, 1994.
24. [24] Costanzo LL, De Guidi G, Cambria A, Famá M: Molecular mechanism of drug sensitization - II: Photohemolysis sensitized by ketoprofen. Photochem Photobiol 50: 359-365, 1989.
25. [25] Gollnick K, Franken T, Schade G, Dörhöfer G: Photosensitized oxygenation as a function of the triplet energy of sensitizers. Ann NY Acad Sci 171: 89-107, 1970.
26. [26] Encinas MV, Scaiano JC: Reaction of benzophenone triplets with allylic hydrogens. A laser flash photolysis study. J Am Chem Soc 103: 6393-6397, 1981.
27. [27] Markovic DZ, Patterson LK: Radical processes in lipids. Selectivity of hydrogen abstraction from lipids by benzophenon triplet. Photochem Photobiol 49: 531-535, 1989.
28. [28] Barclay LRC, Baskin KA, Locke SJ, Schaefer TD: Benzophenone-photosensitized autoxidation of linoleate in solution and sodium dodecyl sulfate micelles. Can J Chem 65: 2529-2540, 1987.